14 Nov 2012 07:00
Tate & Lyle’s SODA-LO™ Salt Microspheres "Most Innovative Health Ingredient of the Year" at NuW Excellence Awards 2012
14 November, 2012 – Tate & Lyle’s ground-breaking, new salt-reduction ingredient, SODA-LO™ Salt Microspheres, was recognized as the "Heart Health and Circulatory Innovation of the Year" and as the overall "Most Innovative Health Ingredient of the Year" from the NuW Excellence Awards, which recognize individuals and business for their exemplary work and contribution to the industry.
"We are proud that a jury of experts recognized both the relevance of SODA-LO™ Salt Microspheres in today’s public health environment and the potential extraordinary value that it delivers to food manufacturers," said Andy Hoffman, Director of Health and Wellness Innovation, Tate & Lyle.
SODA-LO™ Salt Microspheres is a salt reduction ingredient that tastes, labels and functions like salt because it is salt. SODA-LO™ Salt Microspheres reduces salt levels by 25 to 50 percent in various applications including baked goods and salty snacks. SODA-LO™ Salt Microspheres has been created using a patent-pending technology that turns standard salt crystals into free-flowing crystalline microspheres. These smaller, lower-density crystals efficiently deliver salty taste by maximizing surface area relative to volume.
"The development of SODA-LO™ Salt Microspheres is a true case study in innovation helping to overcome a challenge – in this case reducing salt while maintaining taste – and we couldn’t be happier with the results and the commendation from NuW Excellence Awards," said Hoffman.
The winners of the categories were announced at the Messe Frankfurt where the Health Ingredients Europe is taking place until the 15th November 2012. Close to 40 entries were received into the awards with submissions coming from mainland Europe, Taiwan, China and the United States. The NuW Excellence Awards jury panel consisted of 9 leaders in the finished foods, beverages and ingredients industry.
Notes to Editors:
About SODA-LO™ Salt Microspheres:
A salt reduction ingredient, SODA-LO™ Salt Microspheres tastes, labels and functions like salt because it is salt.
Tate & Lyle licensed SODA-LO® from Eminate Ltd, a wholly owned subsidiary of The University of Nottingham, UK, to commercialize it globally. Under the license agreement, Tate & Lyle assumes responsibility for commercialising the SODA-LO® salt reduction technology on a global basis including manufacturing, product development, sales and marketing.
About Health Ingredients Europe & NuW
Health ingredients Europe is part of the world-leading Food Ingredients, Natural Ingredients and Health Ingredients series of ingredients trade shows. These highly professional trade shows have been held successfully since 1986. Health ingredients Europe was launched in 2000 with Hi Europe (NuW) 2012 being the 7th edition of this show. Health Ingredients Europe will be joining NuW Nutrition + Wellness Solutions in 2012, creating a new exhibition that provides a complete 360-degree perspective of the entire nutrition and wellness industry. For more information, visit http://www.nuwsolutions.com
About UBM plc
UBM plc is a leading global company. We inform markets and bring the world's buyers and sellers together at events, online, in print and provide them with the information they need to do business successfully. We focus on serving professional commercial communities, from doctors to game developers, from journalists to jewellery traders, and from farmers to pharmacists around the world. Our 6,600 staff in more than 31 countries are organised into specialist teams that serve these communities, helping them to do business effectively and efficiently.
For more information contact:
About Tate & Lyle:
Tate & Lyle is a global provider of ingredients and solutions to the food, beverage and other industries, operating from over 30 production facilities around the world.
Tate & Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA®
Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate & Lyle sales totalled £3.1 billion. http://www.tateandlyle.com
is a trademark of McNeil Nutritionals, LLC